Developing a DNA test to help diagnose breast cancer
Part of Cancer, Skin clinical trials.
This study is testing a new blood test that looks for chemical changes in your DNA (called epigenetics) to help diagnose breast cancer. If you are a patient at UMMS, your participation could help improve how breast cancer is detected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are a patient at the University of Maryland Medical System (UMMS).
- You are willing and able to give your permission to join the study.
- You can speak and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to help diagnose lung cancer by looking at certain markers in your DNA. Researchers want to see if this test can accurately find lung cancer, which could lead to earlier detection.
This trial tests a blood test that looks for chemical changes in DNA to help diagnose breast cancer. It may offer a simpler way to detect cancer without needing a tissue sample.
This study tests a new blood test that uses epigenetics (chemical markers on DNA) to help diagnose pancreatic cancer. Researchers want to see if this test can accurately identify pancreatic cancer in people who have had it or are at high risk for developing it.
This study uses a blood test to look for DNA changes that could signal cancer early. It includes both people with cancer and healthy volunteers to help build a better screening tool.
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
Hear when a new Breast Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.